Skip to main content
Vaccines logoLink to Vaccines
. 2023 Jul 4;11(7):1197. doi: 10.3390/vaccines11071197

Knowledge, Attitude, and Practice towards Influenza Vaccination among Older Adults in Southern China during the COVID-19 Pandemic

Yating You 1, Xiaoheng Li 2, Binglin Chen 1, Xuan Zou 2, Gang Liu 2,*, Xinxin Han 1,*
Editor: Christian Napoli
PMCID: PMC10384555  PMID: 37515013

Abstract

Influenza is prevalent globally, leading to severe morbidity and mortality. During the pandemic, knowledge, attitude, and practice (KAP) towards influenza virus and vaccination were less investigated among southern Chinese older adults. A cross-sectional study was conducted through the structured questionnaire among community healthcare centers in selected districts in Shenzhen, southern China from September to October 2021. KAP towards influenza virus and vaccination were analyzed. A multivariable logistic regression model was used to identify associated factors. Among 975 participants, 55.6% were reported to have received influenza vaccination ever, and 46.6% had taken influenza vaccination in 2020 during the pandemic. Only one-fifth of participants knew severe comorbidities happen among severe influenza cases. A total of 88.3% thought older adults should have influenza vaccination. COVID-19 vaccination history was associated with receiving influenza vaccination (OR 1.92, 95% CI 1.32–2.80). People with a high-level income had better KAP towards influenza virus and vaccination. COVID-19 vaccination history was associated with the positive actions of influenza vaccination during the pandemic. Efforts should be made to promote the free influenza vaccination program widely and launch health education events on influenza and its vaccination regularly to improve KAP among older adults.

Keywords: influenza, vaccine, older adults, KAP, COVID-19

1. Introduction

Influenza is prevalent globally, leading to severe morbidity and mortality [1,2]. It is estimated that worldwide influenza causes approximately 3 to 5 million cases of severe illness and up to 650,000 respiratory deaths every year [2]. Older adults and people with chronic physical conditions are deemed to be at an increased risk of infection and hospitalization due to influenza [2]. In China, it was estimated that roughly 80% of the excess respiratory deaths attributed to influenza were among people aged 60 years or above between 2010 and 2015 [1,3]. With the evolution of the circulating influenza virus, annual vaccination is recommended as the most effective tool to protect against influenza, as immunity is not lifelong [4,5]. WHO recommends the composition of the trivalent vaccine that targets the three most representative virus types in circulation (two subtypes of influenza A viruses and one influenza B virus) [2]. Hence, launching the influenza vaccination program among older adults is a significant approach to alleviating the influenza disease burden.

With the implementation of national medical reform in China in 2009, vaccination services were provided through community health centers (CHCs), including vaccines for influenza, hepatitis B, human papillomavirus, COVID-19, etc. [6,7]. People of all ages can have influenza vaccine uptakes with their out-of-pocket money of 11 to 49 US dollars (76–334 Chinese Yuan) yearly at widely distributed CHCs in urban areas. During the COVID-19 period, since March 2021, the Chinese government has started to offer the COVID-19 vaccine to older adults for free after domestically comprehensive assessments of health status and infection risks [8]. Although the State Council encouraged local governments to offer free vaccination services to highly-risky populations, including healthcare professionals, children aged between 6 months and 5 years, people with chronic diseases, and others who take care of vulnerable populations, free influenza vaccination services were limited and provided only for older adults in some developed Chinese provinces and cities, for example, Zhejiang Province, Beijing, Guangzhou, as well as our study site, Shenzhen City [9]. Despite many conveniences, compared with influenza vaccination coverage in developed countries, 82.3% in England, 90.2% in Scotland, 75.2% in the United States, 55.0% in Russia, and 56.8% in France during the 2022 flu season, in China, according to previous research, it remained low (4–13%) among older adults [10,11,12,13].

Previous studies focused on the knowledge, attitude, and practice (KAP) of healthcare professionals, pregnant women, travelers, and general workers towards influenza virus and vaccination in different countries and regions [14,15,16,17]. A satisfactory level of knowledge related to COVID-19 and its prevention among the Italian elderly was found [18], which promised a positive attitude and practice towards vaccination. Evidence showed that vaccination-prioritized populations including older adults having insufficient knowledge were associated with low vaccination coverage [19], which indicated that lack of knowledge had an impact on their attitude and practice of vaccination. However, related evidence on the KAP of vaccination is quite limited in China. For example, one study focusing on older adults aged 60 years and above in eastern China was conducted in 2015 to describe early and regional KAP results related to influenza and its vaccination [12]. Less is known about KAP towards influenza virus and vaccination among older adults in southern China during the COVID-19 period with the appearance of free vaccination services.

This study aimed to investigate KAP towards influenza virus and vaccination among 975 Chinese older adults aged 60 years and above and identify associated influenza-related factors with their actions of vaccination. In addition, our study would provide valuable insight into the potential target population and suggest corresponding measures to improve vaccination coverage more efficiently, which is beneficial to promote vaccination-related policy.

2. Materials and Methods

2.1. Study Design and Participants

From 24 September to 20 October 2021, a cross-sectional survey was conducted on the demographic and socioeconomic information, disease and vaccination history, and KAP regarding influenza virus and vaccination in Shenzhen, China. Shenzhen is located in southern China, being one of the first-tier cities with more than 17 million residents. There are 10 districts with more than 700 community health centers in Shenzhen. Ten CHCs in two large districts (Nanshan and Guangming) of Shenzhen were randomly selected as our study sites.

Participants were included through convenient sampling in our study if they (1) were aged 60 years old and above before September 2021; (2) attended the above-included CHCs; and (3) were willing to complete the questionnaire. Considering the feasibility of the study design and the strong mobility of the population in the mega city of Shenzhen, as many participants were included as possible. Overall, 993 older adults were enrolled in our study. Of them, 975 participants had complete information and were valid for data analyses. A total of 18 participants were excluded because they did not state their influenza vaccination status, which was conducted as our primary outcome.

2.2. Data Collection

Trained interviewers administered the structured questionnaire to included participants, asked questions from the questionnaire to each participant, and wrote down the answers in person. Before this questionnaire was made available to all participants, a pilot study was conducted on a small sample of older participants (N = 30) to ensure that the questionnaire was easily understandable and completed. The structured questionnaire consisted of detailed questions on demographic and socioeconomic characteristics, health conditions, KAP on influenza and its vaccination, as well as health education on vaccination.

Demographic and socioeconomic characteristics were measured by sex (female and male), age (60–64, 65–75, and above 75 years old), education level (primary school and below, middle and high school, and college and above), marital status (unmarried and married), and monthly income (1000 and below Chinese Yuan (CNY), 1001–5000, and 5001 and above). Health conditions were assessed by self-awareness of health status (well, general, and worse), chronic disease history (yes and no), and COVID-19 vaccination history (yes and no).

The KAP questionnaire was a part of the structured questionnaire, including knowledge, attitude, and practice towards influenza virus and vaccine. The knowledge survey included influenza virus and vaccine items that were measured by influenza symptoms, prevention measures, vaccination-prioritized populations, vaccination frequencies, vaccination season, vaccine protection duration, the places to get vaccinated, and if they ever knew about influenza vaccine and vaccination policy. The attitude survey included opinions on whether older people and people with chronic diseases should have influenza vaccine uptake and thoughts about vaccination education. The practice survey included cues to actions, vaccine actions, and reasons for being unwilling to receive influenza vaccines. Cues to action consisted of recommendations from healthcare workers, previous vaccination awareness of people around, and participation in vaccine education programs. Actions included self-reported influenza vaccination history before the interview time and in the specific 2020 influenza season. Participants being stratified by influenza vaccination history at that time were categorized as vaccinated status and unvaccinated status as our primary outcome. In addition, participants stratified by influenza vaccination history in the 2020 influenza season were categorized as vaccinated status and unvaccinated status in 2020.

2.3. Statistical Analysis

Statistical analysis was performed with Stata version 17 (StataCorp Inc., Chicago, IL, USA). All categorical variables were described with frequencies (N) and percentages (%). Frequencies and proportions were used to describe the detailed information on knowledge of the influenza virus and vaccine (9 survey items), attitude towards influenza vaccination and its education program (3 survey items), and practice of influenza vaccination (6 survey items). The Chi-square test was used to evaluate the differences in knowledge, attitude, and practice towards influenza virus and vaccination between subgroups, with analyses stratified by age groups, education levels, and income levels. Statistically significant survey items among age groups, education levels, and income levels were included in the following multivariable logistic regression model to identify influenza-associated factors. Demographic and socioeconomic factors stratified by previous actions of influenza vaccine with a p value < 0.05 in the Chi-square test were further included in the same multivariable logistic regression model, where fully adjusted odds ratios (ORs) and their corresponding 95% CI were calculated after controlling for other covariates and associated factors.

Subgroup analysis was conducted among participants who reported as vaccinated in 2020. Statistically significant survey items among age groups, education levels, and income levels were included in the following multivariable logistic regression model to identify influenza-associated factors. Demographic factors stratified by ever received actions of influenza vaccine in 2020 with a p value < 0.05 in the Chi-square test were further included in the same multivariable logistic regression model, where ORs and 95% CIs were calculated. A two-sided p < 0.05 was considered statistically significant in multivariate analyses.

2.4. Ethical Statement

Our study was approved by the Shenzhen Center for Disease Control and Prevention. Oral informed consent was obtained from each participant before interviewers administered and distributed the structured questionnaire.

3. Results

3.1. Characteristics of Participants

A total of 975 older participants were included in this analysis. In Table 1, it can be seen that more females (56.3%) than males (43.7%) were involved in this analysis. The mean age of participants was 69.4 years old, with a standard deviation of 6.4 years old, and 575 (59%) were between 65 and 75 years old. In total, 823 (87.4%) were married and more than half of the participants had middle and high school diplomas, followed by primary school and below. Overall, 429 (44.0%) had middle-income levels of 1000 to 5000 Chinese yuan (CNY), 592 (60.7%) considered their health well and 441 were diagnosed with chronic medical conditions by a doctor before, and 813 (83.4%) had received COVID-19 vaccine uptakes since the breakout of COVID-19 at the beginning of 2020.

Table 1.

Characteristics of study participants in Shenzhen, September 2021 (N = 975).

Characteristics N Percentage (%)
Sex
Female 549 56.3
Male 426 43.7
Age (yrs)
60–64 230 23.6
65–75 575 59.0
Above 75 170 17.4
Marital status
Unmarried 152 15.6
Married 823 87.4
Education level
Primary school and below 338 34.7
Middle and high school 503 51.6
College and above 134 13.7
Monthly income (Chinese Yuan, CNY)
Low (1000 and below) 266 27.3
Middle (1001–5000) 429 44.0
High (5001 and above) 280 28.7
Self-reported health status
Well 592 60.7
General 316 32.4
Worse 67 6.9
Chronic medical conditions
Yes 441 45.2
No 534 54.8
Ever received COVID-19 vaccine uptakes
Yes 813 83.4
No 162 16.6

3.2. Knowledge of Influenza Virus and Vaccination

In Table 2, only one-fifth of participants (N = 214) knew severe comorbidities would happen among severe cases affected by the influenza virus. Most participants knew about vaccination as the approach to protecting against influenza. In total, 75.6% thought people aged 60 years old and above, children aged 6 months to 5 years old, and patients with chronic conditions were the prioritized populations to take influenza vaccine uptakes, but only 13.1% knew that women who were pregnant or planned to become pregnant during flu season should take influenza vaccination. Overall, 64.2% participants knew the influenza vaccination frequency (once a year), 58.4% knew the influenza vaccination time frame (in autumn and winter), 58.4% knew the protection duration (six to eight months), and 74.1% knew the places to take influenza vaccination. Over 70% of participants have heard about influenza vaccination and knew about the free influenza vaccination program in Shenzhen.

Table 2.

Knowledge of the influenza virus and vaccine among older adults in Shenzhen (N = 975).

Items N Percentage (%)
Influenza virus
Q1. What are influenza’s symptoms?
Acute fever (up to 39–40 Celsius degree) 611 62.7
Vomit, diarrhea 251 25.7
Sore joints, fatigue, decreasing appetite 426 43.7
Runny nose, stuffy nose, sneezing 811 83.2
Serious comorbidity will occur in severe cases 214 22.0
Q2. What is the approach to protecting against influenza?
Vaccination 717 73.5
Good hygiene 666 68.3
Enhance physical fitness and immunity 655 67.2
Minimize activities in crowded places 461 47.3
If you have respiratory infection symptoms, you should rest at home and seek medical treatment as soon as possible 473 48.5
Influenza vaccine
a Q3. Who are the priority populations that need to take influenza vaccination?
Healthcare workers 694 71.2
Vulnerable groups and employees 670 68.7
People in key places 424 43.5
Risky populations 737 75.6
Caregivers of infants 266 27.3
Pregnant women 128 13.1
b Q4. Do you know how the influenza vaccination frequency is scheduled?
Once a year 626 64.2
Every 5 years 349 35.8
Have no idea
c Q5. Do you know when to get the influenza vaccine?
In autumn and winter 569 58.4
All year round 406 41.6
Have no idea
d Q6. How long does the flu vaccine protect after a single dose?
6–8 months 424 43.5
At least 5 years 551 56.5
Have no idea
Q7. Do you know where you can get the flu vaccine for seniors?
Yes 722 74.1
No 253 25.9
Q8. Have you ever heard about influenza vaccination for older adults?
Yes 759 77.9
No 216 22.1
Q9. Do you know the policy that older adults aged 60 years and above with Shenzhen household registration could have free influenza vaccination in Shenzhen?
Yes 738 75.7
No 237 24.3

a The details of answers for “Q3. Who are the prioritypopulations that need to take influenza vaccination?” are shown below: healthcare workers, including clinicians, public health staff, and health and quarantine staff; vulnerable groups and employees include people in places where people gather, such as elderly care institutions, long-term care institutions, and welfare homes; people in key places include nursery institutions, primary and secondary schools, and prison institutions; risky populations include older people aged 60 and above, children aged 6 months to 5 years, and patients with specific chronic diseases; infants’ caregivers include family members and caregivers of infants aged under 6 months; pregnant women include women who are pregnant or planning to become pregnant during flu season. b “Once a year” is the correct answer for Q4. c “In autumn and winter” is the correct answer for Q5. d “6–8 months” is the correct answer for Q6.

Most older people knew about vaccination as the method to prevent the influenza virus, the protection duration of influenza vaccine, and the places to take vaccination (p < 0.05 in three survey items in Table 3). Compared with participants with primary school or above education, participants with higher education levels had better knowledge of influenza symptoms, prioritized populations, vaccination frequency, places, protection duration, as well as vaccination policy (p < 0.05 for most survey items in Table 3). So did people who have higher monthly income (p < 0.05 for most survey items). The differences in vaccine protection duration and places existed in each age group, educational level, and income level (p < 0.05 in three subgroups).

Table 3.

Knowledge of the influenza virus and vaccine in the age, education, and income group analysis (N = 975) in Shenzhen, China f.

Items Age (Yrs) a p Value Education Level a p Value Income Level a p Value
60–64 (N = 230) 65–75 (N = 575) Above 75 (N = 170) Primary and Below (N = 338) Middle and High School (N = 503) College and Above (N = 134) Low (N = 266) Middle (N = 429) High (N = 280)
Influenza virus
Q1. What are influenza’s symptoms?
Acute fever 142 (23.2) 361 (59.1) 108 (17.7) 0.931 192 (31.4) 323 (52.9) 96 (15.7) 0.006 146 (23.9) 268 (43.9) 197 (32.2) 0.001
Vomit, diarrhea 59 (23.5) 152 (60.6) 40 (15.9) 0.748 69 (27.5) 139 (55.4) 43 (17.1) 0.012 51 (20.3) 102 (40.6) 98 (39.0) <0.001
Sore joints, fatigue, decreasing appetite 108 (25.4) 251 (58.9) 67 (15.7) 0.323 143 (33.6) 217 (50.9) 66 (15.5) 0.366 111 (26.1) 168 (39.4) 147 (34.5) 0.002
Runny nose, stuffy nose, sneezing 195 (24) 472 (58.2) 144 (17.8) 0.550 297 (36.6) 410 (50.6) 104 (12.8) 0.010 225 (27.7) 357 (44.0) 229 (28.2) 0.682
Serious comorbidity 43 (20.1) 131 (61.2) 40 (18.7) 0.386 53 (24.8) 114 (53.3) 47 (22) <0.001 43 (20.1) 85 (39.7) 86 (40.2) <0.001
Q2. What is the approach to protecting against influenza?
Vaccination 151 (21.1) 431 (60.1) 135 (18.8) 0.004 234 (32.6) 374 (52.2) 109 (15.2) 0.022 165 (23.0) 310 (43.2) 242 (33.8) <0.001
Good hygiene 157 (23.6) 400 (60.1) 109 (16.4) 0.407 213 (32) 355 (53.3) 98 (14.7) 0.030 151 (22.7) 297 (44.6) 218 (32.7) <0.001
Enhance physical fitness and immunity 145 (22.1) 393 (60) 117 (17.9) 0.309 218 (33.3) 336 (51.3) 101 (15.4) 0.074 156 (23.8) 280 (42.7) 219 (33.4) <0.001
Minimize activities in crowded places 102 (22.1) 274 (59.4) 85 (18.4) 0.514 148 (32.1) 238 (51.6) 75 (16.3) 0.057 98 (21.3) 196 (42.5) 167 (36.2) <0.001
Rest at home and seek medical treatment 113 (23.9) 278 (58.8) 82 (17.3) 0.977 157 (33.2) 247 (52.2) 69 (14.6) 0.570 110 (23.3) 202 (42.7) 161 (34.0) 0.001
Influenza vaccine
b Q3. Who are the priority populations that need to take influenza vaccination?
Healthcare workers 152 (21.9) 417 (60.1) 125 (18) 0.144 216 (31.1) 366 (52.7) 112 (16.1) <0.001 150 (21.6) 300 (43.2) 244 (35.2) <0.001
Vulnerable groups and employees 153 (22.8) 390 (58.2) 127 (19) 0.168 220 (32.8) 346 (51.6) 104 (15.5) 0.030 160 (23.9) 280 (41.8) 230 (34.3) <0.001
People in key places 93 (21.9) 251 (59.2) 80 (18.9) 0.415 120 (28.3) 234 (55.2) 70 (16.5) 0.001 90 (21.2) 185 (43.6) 149 (35.1) <0.001
Risky populations 169 (22.9) 439 (59.6) 129 (17.5) 0.690 265 (36) 374 (50.7) 98 (13.3) 0.316 192 (26.1) 326 (44.2) 219 (29.7) 0.252
Infants’ caregivers 64 (24.1) 148 (55.6) 54 (20.3) 0.294 85 (32) 133 (50) 48 (18) 0.053 63 (23.7) 113 (42.5) 90 (33.8) 0.072
Pregnant women 29 (22.7) 68 (53.1) 31 (24.2) 0.091 34 (26.6) 67 (52.3) 27 (21.1) 0.014 28 (21.9) 50 (39.1) 50 (39.1) 0.019
c Q4. Do you know how the influenza vaccination frequency is scheduled?
Once a year 140 (22.4) 380 (60.7) 106 (16.9) 0.324 181 (28.9) 346 (55.3) 99 (15.8) <0.001 140 (22.4) 259 (41.4) 227 (36.3) <0.001
Every 5 years 90 (25.8) 195 (55.9) 64 (18.3) 157 (45.0) 157 (45.0) 35 (10.0) 126 (36.1) 170 (48.7) 53 (15.2)
Have no idea
d Q5. Do you know when to get the influenza vaccine?
In autumn and winter 129 (22.7) 344 (60.5) 96 (16.9) 0.536 162 (28.5) 308 (54.1) 99 (17.4) <0.001 122 (21.4) 244 (42.9) 203 (35.7) <0.001
All year round 101 (24.9) 231 (56.9) 74 (18.2) 176 (43.3) 195 (48.0) 35 (8.6) 144 (35.5) 185 (45.6) 77 (19.0)
Have no idea
e Q6. How long does the flu vaccine protect after a single dose?
6–8 months 82 (19.3) 267 (63) 75 (17.7) 0.020 106 (25) 231 (54.5) 87 (20.5) <0.001 74 (17.5) 182 (42.9) 168 (39.6) <0.001
At least 5 years 148 (26.9) 308 (55.9) 95 (17.2) 232 (42.1) 272 (49.4) 47 (8.5) 192 (34.8) 247 (44.8) 112 (20.3)
Have no idea
Q7. Do you know the places where you can get the flu vaccine for seniors?
Yes 154 (21.3) 449 (62.2) 119 (16.5) 0.002 225 (31.2) 387 (53.6) 110 (15.2) <0.001 156 (21.6) 321 (44.5) 245 (33.9) <0.001
No 76 (30.0) 126 (49.8) 51 (20.2) 113 (44.7) 116 (45.8) 24 (9.5) 110 (43.5) 108 (42.7) 35 (13.8)
Q8. Have you ever heard about influenza vaccination for older adults?
Yes 167 (22) 458 (60.3) 134 (17.7) 0.089 238 (31.4) 400 (52.7) 121 (15.9) <0.001 160 (21.1) 344 (45.3) 255 (33.6) <0.001
No 63 (29.2) 117 (54.2) 36 (16.7) 100 (46.3) 103 (47.7) 13 (6.0) 106 (49.1) 85 (39.4) 25 (11.6)
Q9. Do you know the policy that older adults aged 60 years and above with Shenzhen household registration could have free influenza vaccination in Shenzhen?
Yes 163 (22.1) 449 (60.8) 126 (17.1) 0.085 230 (31.2) 392 (53.1) 116 (15.7) <0.001 155 (21) 332 (45) 251 (34) <0.001
No 67 (28.3) 126 (53.2) 44 (18.6) 108 (45.6) 111 (46.8) 18 (7.6) 111 (46.8) 97 (40.9) 29 (12.2)

a p value is calculated from a Chi-square test. b The details of answers for “Q3. Who are the priority populations that need to take influenza vaccination?” are shown below: healthcare workers, including clinicians, public health staff, and health and quarantine staff; vulnerable groups and employees include people in places where people gather, such as elderly care institutions, long-term care institutions, and welfare homes; people in key places include nursery institutions, primary and secondary schools, and prison institutions; risky populations include older people aged 60 and above, children aged 6 months to 5 years, and patients with specific chronic diseases; infants’ caregivers include family members and caregivers of infants aged under 6 months; pregnant women include women who are pregnant or planning to become pregnant during flu season. c “Once a year” is the correct answer for Q4. d “In autumn and winter” is the correct answer for Q5. e “6–8 months” is the correct answer for Q6. f The number inside of brackets indicates percentages and outside of brackets indicates frequency.

3.3. Attitude towards Influenza Vaccination and Education Program

In Table 4, 861 (88.3%) participants thought older adults should take influenza vaccination and over half considered that older adults with chronic medical conditions were bound to take the vaccination. A total of 652 (65.9%) thought it beneficial to participate in the vaccination education program.

Table 4.

Attitudes towards the influenza vaccination and education program among older adults (N = 975) in Shenzhen, China.

Items N Percentage (%)
Q1. Do you think older adults should take influenza vaccination?
Yes 861 88.3
No 114 11.7
Q2. Do you think older adults with chronic medical conditions should take influenza vaccination?
Yes 550 57.1
No 425 43.6
Q3. Do you think participating in a health education program is beneficial for you to learn knowledge about vaccination?
Yes 652 66.9
No 323 33.1

Most participants (58.9%) between 65 and 74 years old thought older adults diagnosed with chronic conditions should take influenza vaccination compared with the other two age groups (20.9% vs. 58.9% vs. 20.2%, p = 0.010 in Table 5). People with middle and high school education or middle level of income had a more positive attitude towards influenza vaccination and education programs, showing more agreement in three survey items (p < 0.05 in Table 5). The differences in attitudes towards vaccination among older adults with chronic diseases existed in each age group, educational level, and income level (p < 0.05 in three subgroups).

Table 5.

Attitudes towards the influenza vaccine and education program in the age, education, and income group analysis (N = 975) in Shenzhen, China b.

Items Age (Yrs) a p Value Education Level a p Value Income Level a p Value
60~64 (N = 230) 65~75 (N = 575) Above 75 (N = 170) Primary and Below (N = 338) Middle and High School (N = 503) College and Above (N = 134) Low (N = 266) Middle (N = 429) High (N = 280)
Q1. Do you think older adults should take influenza vaccination?
No 28 (24.6) 64 (56.1) 22 (19.3) 0.785 53 (46.5) 51 (44.7) 10 (8.8) 0.013 52 (45.6) 45 (39.5) 17 (14.9) <0.001
Yes 202 (23.5) 511 (59.3) 148 (17.2) 285 (33.1) 452 (52.5) 124 (14.4) 214 (24.9) 384 (44.6) 263 (30.5)
Q2. Do you think older adults with chronic medical conditions should take influenza vaccination?
No 115 (27.1) 251 (59.1) 59 (13.9) 0.010 172 (40.5) 211 (49.6) 42 (9.9) <0.001 140 (32.9) 195 (45.9) 90 (21.2) <0.001
Yes 115 (20.9) 324 (58.9) 111 (20.2) 166 (30.2) 292 (53.1) 92 (16.7) 126 (22.9) 234 (42.5) 190 (34.5)
Q3. Do you think participating in a health education program is beneficial for you to learn knowledge about vaccination?
No 74 (22.9) 186 (57.6) 63 (19.5) 0.487 137 (42.4) 160 (49.5) 26 (8) <0.001 134 (41.5) 128 (39.6) 61 (18.9) <0.001
Yes 156 (23.9) 389 (59.7) 107 (16.4) 201 (30.8) 343 (52.6) 108 (16.6) 132 (20.2) 301 (46.2) 219 (33.6)

a p value is calculated from a Chi-square test. b The number inside of brackets indicates percentages and outside of brackets indicates frequency.

3.4. Practices of Influenza Vaccination

In Table 6, cues to actions of influenza vaccination included three items as follows: 653 (67.0%) participants were recommended the influenza vaccination by healthcare workers, but 542 (55.6%) reported to have received influenza vaccination and 454 (46.6%) have taken influenza vaccine uptakes in 2020 during the COVID-19 period. Around 60% of participants heard about people around who have taken influenza uptakes. One-third of participants have ever taken part in health education programs. In Table 7, additionally, the associations of vaccinated people around previous vaccination status and vaccination status in 2020 differed by age, education, and income levels (p < 0.05). Participants among 65 to 74 years old, holding middle and high school diplomas, or with higher income levels, were reported to have received influenza vaccination and taken influenza vaccine uptakes in 2020 (p < 0.05).

Table 6.

Practices of the influenza vaccination among older adults (N = 975) in Shenzhen, China.

Items N Percentage (%)
Cues to actions
Q1. Did community health workers recommend the influenza vaccination to you?
Yes 653 67.0
No 322 33.0
Q2. Are there any older adults around you who had influenza vaccination?
Yes 580 59.5
No 395 40.5
Q3. Ever participated in a health education activity?
Yes 333 34.2
No 642 65.8
Actions
Q4. Have you ever received influenza vaccination?
No, never received 433 44.4
Yes, ever received 542 55.6
Q5. Have you received influenza vaccination in 2020?
No 521 53.4
Yes 454 46.6
Q6. Reasons for being unwilling or unsure to receive the influenza vaccines
Stay at a good condition, no need to take vaccine 119 27.5
Do not know about vaccination 186 43.0
Influenza vaccine is not safe enough 28 6.4
Influenza vaccine has no effect 12 2.8
Have no time to take vaccine 54 12.5
Influenza is not important and will not lead to any serious results 30 6.9
It is inconvenient to go to the vaccination places 45 10.4
The cost of vaccination is too much 23 5.3
Physicians do not recommend it 24 5.5
Others 52 12.0

Table 7.

Practices towards the influenza vaccine in the age, education, and income group analysis (N = 975) in Shenzhen, China b.

Items Age (Yrs) a p Value Education Level a p Value Income Level a p Value
60–64 (N = 230) 65–75 (N = 575) Above 75 (N = 170) Primary and Below (N = 338) Middle and High School (N = 503) College and Above (N = 134) Low (N = 266) Middle (N = 429) High (N = 280)
Q1. Did community health workers recommend the influenza vaccination to you?
No 87 (27.0) 180 (55.9) 55 (17.1) 0.202 140 (43.5) 156 (48.4) 26 (8.1) <0.001 130 (40.4) 137 (42.5) 55 (17.1) <0.001
Yes 143 (21.9) 395 (60.5) 115 (17.6) 198 (30.3) 347 (53.1) 108 (16.5) 136 (20.8) 292 (44.7) 225 (34.5)
Q2. Are there any older adults around you who had influenza vaccination?
No 115 (29.1) 212 (53.7) 68 (17.2) 0.003 163 (41.3) 192 (48.6) 40 (10.1) <0.001 150 (38.0) 171 (43.3) 74 (18.7) <0.001
Yes 115 (19.8) 363 (62.6) 102 (17.6) 175 (30.2) 311 (53.6) 94 (16.2) 116 (20.0) 258 (44.5) 206 (35.5)
Q3. Ever participated in a health education activity?
No 161 (25.1) 364 (56.7) 117 (18.2) 0.130 254 (39.6) 306 (47.7) 82 (12.8) <0.001 217 (33.8) 265 (41.3) 160 (24.9) <0.001
Yes 69 (20.7) 211 (63.4) 53 (15.9) 84 (25.2) 197 (59.2) 52 (15.6) 49 (14.7) 164 (49.2) 120 (36.0)
Q4. Have you ever received influenza vaccination?
No 130 (30.0) 238 (55.0) 65 (15.0) <0.001 186 (43.0) 209 (48.3) 38 (8.8) <0.001 166 (38.3) 200 (46.2) 67 (15.5) <0.001
Yes 100 (18.5) 337 (62.2) 105 (19.4) 152 (28.0) 294 (54.2) 96 (17.7) 100 (18.5) 229 (42.3) 213 (39.3)
Q5. Have you received influenza vaccination in 2020?
No 142 (27.3) 298 (57.2) 81 (15.5) 0.010 212 (40.7) 252 (48.4) 57 (10.9) <0.001 179 (34.4) 235 (45.1) 107 (20.5) <0.001
Yes 88 (19.4) 277 (61.0) 89 (19.6) 126 (27.8) 251 (55.3) 77 (17.0) 87 (19.2) 194 (42.7) 173 (38.1)

a p value is calculated from a Chi-square test. b The number inside of brackets indicates percentages and outside of brackets indicates frequency.

3.5. Reasons for Being Unwilling to Receive the Influenza Vaccines

Among 433 participants who reported not receiving influenza vaccination before, their reasons for being not vaccinated are presented in Table 6. The top three reasons were as follows: participants reported that they did not know about influenza vaccination (43.0%); they thought they stayed in good conditions and there was no need to take the influenza vaccine (27.5%); and they had no time to take the influenza vaccine (12.5%). It is worth noticing that only 2.8% of participants thought the influenza vaccine had no effect. Only 24 (5.5%) participants did not have the influenza vaccine because physicians have not ever recommended it, and another 23 (5.3%) considered it too much cost.

3.6. Multivariate Analysis

Using the actions of influenza vaccination as the primary outcome, a multivariate analysis was conducted to determine what variables were associated with our primary outcome. The differences in influenza vaccination status existed in knowledge items of influenza vaccination protective duration, the places to have influenza uptakes, and attitudes towards whether older adults with chronic conditions should take influenza vaccination. In Table 8, compared with younger participants less than 65 years old, participants aged above 65 years old were at higher odds of being vaccinated, with the odds ratio of 1.46 (95% CI 1.02–2.10) for the 65–75 age group and the odds ratio of 1.81 (95% CI 1.10–2.98) for the above 75 age group. Marital status and education levels were not associated with influenza vaccinated status after adjusting for other significant influenza-associated factors. Participants who had a high-level monthly income were associated with higher odds of being vaccinated (5001 and above CNY: OR 2.64, 95% CI 1.66–4.18). COVID-19 vaccination history was not statistically significantly associated with our primary outcome of previous vaccination status before the year 2020. Participants who answered correctly on vaccination protection duration were associated with having influenza vaccine uptakes (OR 2.76, 95% CI 1.99–3.84). Participants who knew about the places of vaccination were associated with the vaccinated status (OR 5.00, 95% CI 3.42–7.32). Moreover, participants who thought older adults with chronic conditions should take influenza vaccination were associated with having vaccination (OR 2.08, 95% CI 1.51–2.85).

Table 8.

Multivariate regression analysis of the associated factors of covariates on the previous actions of influenza vaccination and actions.

Factors Actions of Vaccination Actions of Vaccination in 2020
Never Received N (%) Ever Received N (%) a p Value OR (95% CI) Not Received N (%) Received N (%) p Value OR (95% CI)
Sex
Female 239 (43.5) 310 (56.5) 0.532 290 (52.8) 259 (47.2) 0.663
Male 194 (45.5) 232 (54.5) 231 (54.2) 195 (45.8)
Age (yrs)
60–64 130 (56.5) 100 (43.5) <0.001 ref 142 (61.7) 88 (38.3) 0.010 ref
65–75 238 (41.4) 337 (58.6) 1.46 (1.01, 2.10) 298 (51.8) 277 (48.2) 1.18 (0.83, 1.68)
Above 75 65 (38.2) 105 (61.8) 1.81 (1.10, 2.98) 81 (47.6) 89 (52.4) 1.80 (1.11, 2.92)
Marital status
Unmarried 86 (56.6) 66 (43.4) 0.001 ref 103 (67.8) 49 (32.2) <0.001 ref
Married 347 (42.2) 476 (57.8) 1.18 (0.77, 1.84) 418 (50.8) 405 (49.2) 1.54 (0.99, 2.36)
Education level
Primary school and below 186 (55.0) 152 (45.0) <0.001 ref 212 (62.7) 126 (37.3) <0.001 ref
Middle and high school 209 (41.6) 294 (58.4) 1.12 (0.79, 1.60) 252 (50.1) 251 (49.9) 1.14 (0.81, 1.60)
College and above 38 (28.4) 96 (71.6) 1.12 (0.64, 1.96) 57 (42.5) 77 (57.5) 0.94 (0.57, 1.56)
Monthly income (CNY)
Low (1000 and below) 166 (62.4) 100 (37.6) <0.001 ref 179 (67.3) 87 (32.7) <0.001 ref
Middle (1001–5000) 200 (46.6) 229 (53.4) 1.32 (0.90, 1.92) 235 (54.8) 194 (45.2) 1.19 (0.82, 1.73)
High (5001 and above) 67 (23.9) 213 (76.1) 2.64 (1.66, 4.18) 107 (38.2) 173 (61.8) 1.69 (1.10, 2.61)
Self-reported health status
Well 265 (44.8) 327 (55.2) 0.442 306 (51.7) 286 (48.3) 0.197
General 134 (42.4) 182 (57.6) 173 (54.7) 143 (45.3)
Worse 34 (50.7) 33 (49.3) 42 (62.7) 25 (37.3)
Chronic medical conditions
No 223 (41.8) 311 (58.2) 0.067 240 (54.4) 201 (45.6) 0.575
Yes 210 (47.6) 231 (52.4) 281 (52.6) 253 (47.4)
Received COVID-19 vaccine uptakes
No 83 (51.2) 79 (48.8) 0.056 106 (65.4) 56 (34.6) 0.001 ref
Yes 350 (43.1) 463 (56.9) 415 (51.0) 398 (49.0) 1.57 (1.05, 2.37)
How long does the flu vaccine protect after a single dose?
At least 5 years 336 (61.0) 215 (39.0) <0.001 ref 372 (67.5) 179 (32.5) <0.001 ref
Have no idea
6–8 months 97 (22.9) 327 (77.1) 2.76 (1.99, 3.84) 149 (35.1) 275 (64.9) 2.15 (1.58, 2.93)
Do you know where you can get the flu vaccine for seniors?
No 203 (80.2) 50 (19.8) <0.001 ref 309 (42.8) 413 (57.2) <0.001 ref
Yes 230 (31.9) 492 (68.1) 5.00 (3.42, 7.32) 212 (82.8) 41 (16.2) 4.22 (2.85, 6.24)
Do you think older adults with chronic medical conditions should take influenza vaccination?
No 267 (62.8) 158 (37.2) <0.001 ref 294 (69.2) 131 (30.8) <0.001 ref
Yes 166 (30.2) 384 (69.8) 2.08 (1.51, 2.85) 227 (41.3) 323 (58.7) 1.73 (1.27, 2.35)

a p value is calculated from multivariable regression analysis.

3.7. Subgroup Analysis

In subgroup analysis, another multivariate regression model stratified by the actions of the influenza vaccine in 2020 was conducted. Identified influenza-associated factors were similar to the results stratified by previous actions of influenza vaccination, but during the COVID-19 period, COVID-19 vaccination history was associated with receiving influenza vaccine uptakes (OR 1.57, 95% CI 1.05–2.37). Participants who had a high-level monthly income were associated with higher odds of being vaccinated (5001 and above CNY: OR 1.69, 95% CI 1.10–2.61). Participants who answered correctly on vaccination protection duration were associated with having influenza vaccine uptakes (OR 2.15, 95% CI 1.58–2.93). Participants who knew about the places of vaccination were associated with the vaccinated status (OR 4.22, 95% CI 2.85–6.24). Moreover, participants who thought older adults with chronic conditions should take influenza vaccination were associated with having vaccination (OR 1.73, 95% CI 1.27–2.35).

4. Discussion

A cross-sectional survey was conducted to evaluate the knowledge, attitudes, and practices toward influenza virus and vaccination among 975 Chinese older adults aged 60 years and above and identify influenza vaccination-associated factors from September to October 2021 in southern China. The vaccination coverage was 55.6% among our participants. People with a higher education or income level had a better performance of knowledge, attitude, and practice towards influenza virus and vaccination. People with higher income levels and better knowledge and attitude were associated with the positive actions of influenza vaccination.

As a result of complex and diverse vaccination policies being implemented in different cities in China, the vaccination coverage rate showed differences among older populations, for example, 55.6% in this study, being much higher than those of previous studies among older adults, ranging from 4.3% to 40.0% [20], but lower than that of the US in 2022 [21]. This difference might be attributed to the fact that people living in Shenzhen are provided with fruitful medical resources and health information offerings from the high-quality primary healthcare system supported by the municipal government [22]. Additionally, evidence showed that health literacy was apparently higher among people in Shenzhen compared with the Chinese average level, which referred to the ability and basic diathesis to acquire and use health information and make health-associated associations, for example, vaccination in the present study [23,24]. Statistically significant influenza-associated factors in knowledge and attitude survey items were identified, which showed that people having sufficient and correct knowledge as well as positive attitude towards influenza vaccination were associated with having vaccination. However, four-fifths of participants were not aware of the occurrence of severe comorbidity, which made people look down upon influenza. A large proportion of them did not know pregnant women as one of the risky populations of infection, which potentially poses a threat to pregnant women and their babies. This reflected the knowledge barriers among our participants. Appropriate health education programs are urgently needed among older adults.

Previous studies focused on healthcare professionals, pregnant women, and travelers in different regions with the impact of vaccination policies [14,16,17]. Evidence showed that an appropriate vaccination policy indeed has a positive impact on the coverage rate [25], which indicated that a free vaccination policy might attract more attention. The study site, Shenzhen, as the first-tier city in China, has already provided free influenza vaccination among older permanent residents aged 60 years or above for 7 years. Previous studies also proved a positive influence on influenza vaccination coverage under the launch of free influenza vaccination programs for older adults [26]. Vaccination policy was considered one of the most significant vaccination-related factors [27]. Our study also affirmed this factor, stating that older adults who ever knew about the free vaccination program were associated with having the influenza vaccine uptake. This beneficial policy should be generalized among other capable cities to improve influenza vaccination coverage among older adults.

Almost 90% of participants agreed that older adults should take influenza vaccination, but only half of our participants had influenza vaccine uptakes before. The older participants who were less educated were associated with not having influenza vaccination in this study compared with participants with higher education levels. It is consistent with previous studies, indicating that people with low literacy might ignore written information [28], for example, leaflets and posters on free influenza vaccination in CHCs. However, older participants with higher education or income levels in this study knew more about older adults who had influenza vaccination before. It is possible that they were influenced to have vaccine uptakes by their acquaintances, that is, the acquaintance effect. This factor needs to be explored in vaccination studies further.

The popularity of influenza vaccination was limited to some degree because almost half of the unvaccinated participants reported they did not know about the vaccination program as the top reason. This indicated that the influenza vaccination program should strengthen promotion among the public mass. A small proportion of people considered themselves healthy enough for it to be unnecessary to have influenza uptakes, which was the second reason. This demonstrated the misunderstanding of susceptible populations regarding influenza virus and the necessity of vaccination education programs widely and regularly. Despite the shortages of vaccination programs, a few people thought the influenza vaccine had no effect, which indicated that vaccination education played an important role in improving vaccine-associated knowledge. Several participants mentioned that they were not recommended to have influenza vaccine uptakes by their physicians, but recommending vaccination was supposed to be their work responsibility in our previous studies [26]. This reflected deficiencies in physicians’ work to some degree.

COVID-19 vaccination history was found to be associated with influenza vaccination in 2020, which might be due to their good level of perception on both viruses and their vaccines, being consistent with a cross-sectional study focusing on the knowledge related to COVID-19 among the Italian elderly [18]. During the 2020 flu season with the pandemic, many people perceived the COVID-19 virus as the influenza virus mistakenly because of their similar symptoms, and people were willing to have influenza vaccination when there was no COVID-19 vaccine approved. Our findings suggested that participants with higher education and income levels are associated with having influenza vaccine uptake. Moreover, health and vaccine information on COVID-19 was gradually promoted widely and deeply during the pandemic [29]. The promotion of influenza education cannot reach the point of COVID-19, obviously. Nowadays, with the decreasing cases of COVID-19 daily, the new cases of type A influenza have started to increase and the positive rate is up to 25.1% [30]. Hence, it is urgent to promote influenza and influenza vaccination-related information in China, especially for older adults.

Physicians were reported as a significant factor in multiple studies [15,31]. In our study, similarly, 67% of participants were recommended the influenza vaccination by healthcare workers, and only a few participants stated their un-vaccination status was due to no recommendation from professionals, but half of them were influenza vaccinated. Hence, providing recommendations from professionals is the most convenient and reliable method to improve the influenza vaccination-associated information as well as coverage rate. However, vaccine hesitancy existed among both patients and healthcare professionals. Patients worry about the inefficacy of vaccines and the fear of adverse effects [32]. Professionals may have concerns about the responsibility of medical accidents if an allergy reaction or severe side effects appear after patients’ follow the recommendation of vaccination from them, which needs further investigation as to the reason for not recommending vaccination. Hence, to eliminate vaccine hesitancy, proper and correct vaccination education is needed among healthcare professionals and patients regularly.

Several limitations of this study must be acknowledged. First, recall bias might exist when responding to past experiences. For example, previous vaccination status as our primary outcome was self-reported. Second, considering that the sample was from Shenzhen, where adults aged 60 and above take the proportion of 5.36% (0.95 million), compared with the national average of 18.7% [33,34], our study results might not be generalized to other Chinese cities. Moreover, Shenzhen, as one of four first-tier super cities with the top gross national product in China, is capable of offering financial support for multiple vaccination programs for specific populations. Hence, other governments should tailor their vaccination policy. Third, selection bias might exist, as only participants who visited the included CHCs were included. Fourth, because of the nature of study design, this survey was conducted at the beginning of the influenza season and the attitudes and practices only reflected the information available at a certain point. The actual KAP may have changed after our study period. Future study is needed to assess the KAP towards influenza virus and vaccination among risky populations after the COVID-19 pandemic for further vaccination policy making.

5. Conclusions

In conclusion, our study provided valuable insights into the free influenza vaccination policy, which played a significant role in improving vaccination coverage. A relatively high vaccination coverage was found among older adults in Shenzhen. People with higher income levels had a better performance of knowledge, attitude, and practice towards influenza virus and vaccination. COVID-19 vaccination history was associated with the actions of influenza vaccination during the pandemic. Therefore, more actions from the government should be taken to improve influenza vaccination coverage among older adults through providing health education regularly to improve knowledge and attitudes and delivering wide promotion of the free influenza vaccination program to facilitate older adults’ practices.

Acknowledgments

We would like to thank all involved participants and physicians in each community healthcare center and Shenzhen Center for Disease Control and Prevention for their contribution to this study.

Author Contributions

Conceptualization, X.H. and G.L.; Methodology, X.H.; Software, Y.Y.; Formal Analysis, Y.Y.; Investigation, G.L. and X.L.; Resources, X.Z. and G.L.; Data Curation, G.L.; Writing—Original Draft Preparation, Y.Y.; Writing—Review and Editing, Y.Y., X.L., B.C., G.L. and X.H.; Supervision, X.H.; Project Administration, X.H. All authors have read and agreed to the published version of the manuscript.

Institutional Review Board Statement

The survey study was reviewed and approved by the Institutional Review Board of Shenzhen Center for Disease Prevention and Control.

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

Data will be made available on request.

Conflicts of Interest

The authors declare that they have no known competing financial interest or personal relationship that could have appeared to influence the work reported in this paper.

Funding Statement

This research received no external funding.

Footnotes

Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

References

  • 1.Li L., Liu Y., Wu P., Peng Z., Wang X., Chen T., Wong J.Y.T., Yang J., Bond H.S., Wang L., et al. Influenza-associated excess respiratory mortality in China, 2010–2015: A population-based study. Lancet Public Health. 2019;4:e473–e481. doi: 10.1016/S2468-2667(19)30163-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.WHO Influenza (Seasonal) [(accessed on 19 January 2023)]; Available online: https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal)
  • 3.Feng L., Shay D.K., Jiang Y., Zhou H., Chen X., Zheng Y., Jiang L., Zhang Q., Lin H., Wang S., et al. Influenza-associated mortality in temperate and subtropical Chinese cities, 2003–2008. Bull. World Health Organ. 2012;90:279–288b. doi: 10.2471/BLT.11.096958. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Chinese Center for Disease Control and Prevention Technical Guidelines for Influenza Vaccination in China (2022–2023) [(accessed on 21 February 2023)]; Available online: https://www.chinacdc.cn/yyrdgz/202208/t20220825_260956.html.
  • 5.Petrova V.N., Russell C.A. The evolution of seasonal influenza viruses. Nat. Rev. Microbiol. 2018;16:47–60. doi: 10.1038/nrmicro.2017.118. [DOI] [PubMed] [Google Scholar]
  • 6.General Office of the State Council The General Office of the State Council on the Distribution of the Medical and Health System-Notice of the Work Schedule for 2009 on Five Key Reforms. [(accessed on 6 March 2023)]; Available online: https://www.gov.cn/zwgk/2009-07/23/content_1372946.htm.
  • 7.Government of China The COVID-19 Vaccine Is Free for All and the Health Insurance Fund and the Treasury Share the Burden. [(accessed on 6 March 2023)]; Available online: http://www.gov.cn/fuwu/2021-01/09/content_5578430.htm.
  • 8.NHC—National Health Commission: The Elderly over 60 Years Old Will Start Large-Scale Vaccination of the New Crown Vaccine. [(accessed on 14 June 2023)]; Available online: https://www.gov.cn/xinwen/2021-03/22/content_5594346.htm.
  • 9.Government of China Focus on the Notice on Influenza Prevention and Control in the 2021–2022 Epidemic Season. [(accessed on 16 May 2023)]; Available online: http://www.gov.cn/xinwen/2021-10/18/content_5643354.htm.
  • 10.Center for Disease Control and Prevention Flu Vaccination Coverage, United States, 2020–2021 Influenza Season. [(accessed on 19 January 2023)]; Available online: https://www.cdc.gov/flu/fluvaxview/coverage-2021estimates.htm.
  • 11.UK Government Surveillance of Influenza and Other Seasonal Respiratory Viruses in Winter 2021 to 2022. [(accessed on 19 January 2023)]; Available online: https://www.gov.uk/government/statistics/annual-flu-reports/surveillance-of-influenza-and-other-seasonal-respiratory-viruses-in-winter-2021-to-2022#vaccination.
  • 12.Wendlandt R., Cowling B.J., Chen Y., Havers F., Shifflett P., Song Y., Zhang R., Iuliano D., Xu C., Yu H., et al. Knowledge, attitudes and practices related to the influenza virus and vaccine among older adults in Eastern China. Vaccine. 2018;36:2673–2682. doi: 10.1016/j.vaccine.2018.03.052. [DOI] [PubMed] [Google Scholar]
  • 13.WHO Influenza Vaccination Coverage. [(accessed on 13 June 2023)]; Available online: https://immunizationdata.who.int/pages/coverage/flu.html?CODE=FRA&ANTIGEN=FLU_ELDERLY&YEAR=
  • 14.Erazo C.E., Erazo C.V., Grijalva M.J., Moncayo A.L. Knowledge, attitudes and practices on influenza vaccination during pregnancy in Quito, Ecuador. BMC Public Health. 2021;21:72. doi: 10.1186/s12889-020-10061-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Ma Y., Li T., Chen W., Chen J., Li M., Yang Z. Knowledge, Attitudes and Practices (KAP) toward seasonal influenza vaccine among young workers in South China. Hum. Vaccines Immunother. 2018;14:1283–1293. doi: 10.1080/21645515.2017.1423157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Madewell Z., Chacón-Fuentes R., Badilla-Vargas X., Ramirez C., Ortiz M.-R., Alvis-Estrada J.-P., Jara J. Knowledge, attitudes, and practices for the use of seasonal influenza vaccination, healthcare workers, Costa Rica. J. Infect. Dev. Ctries. 2021;15:1004–1013. doi: 10.3855/jidc.14381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Pfeil A., Mütsch M., Hatz C., Szucs T.D. A cross-sectional survey to evaluate knowledge, attitudes and practices (KAP) regarding seasonal influenza vaccination among European travellers to resource-limited destinations. BMC Public Health. 2010;10:402. doi: 10.1186/1471-2458-10-402. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Gallè F., Sabella E.A., Roma P., Ferracuti S., Da Molin G., Diella G., Montagna M.T., Orsi G.B., Liguori G., Napoli C. Knowledge and Lifestyle Behaviors Related to COVID-19 Pandemic in People over 65 Years Old from Southern Italy. Int. J. Environ. Res. Public Health. 2021;18:872. doi: 10.3390/ijerph182010872. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Blank P.R., Schwenkglenks M., Szucs T.D. Vaccination coverage rates in eleven European countries during two consecutive influenza seasons. J. Infect. 2009;58:446–458. doi: 10.1016/j.jinf.2009.04.001. [DOI] [PubMed] [Google Scholar]
  • 20.Wang Q., Yue N., Zheng M., Wang D., Duan C., Yu X., Zhang X., Bao C., Jin H. Influenza vaccination coverage of population and the factors influencing influenza vaccination in mainland China: A meta-analysis. Vaccine. 2018;36:7262–7269. doi: 10.1016/j.vaccine.2018.10.045. [DOI] [PubMed] [Google Scholar]
  • 21.Center for Disease Control and Prevention Flu Vaccination Coverage, United States, 2021–2022 Influenza Season. [(accessed on 19 January 2023)]; Available online: https://www.cdc.gov/flu/fluvaxview/coverage-2022estimates.htm.
  • 22.Li X., Krumholz H.M., Yip W., Cheng K.K., De Maeseneer J., Meng Q., Mossialos E., Li C., Lu J., Su M., et al. Quality of primary health care in China: Challenges and recommendations. Lancet. 2020;395:1802–1812. doi: 10.1016/S0140-6736(20)30122-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Nielsen-Bohlman L., Panzer A.M., Kindig D.A., editors. Health Literacy: A Prescription to End Confusion. National Academies Press (US); Washington, DC, USA: 2004. Institute of Medicine (US) Committee on Health Literacy. [PubMed] [Google Scholar]
  • 24.Zhang L., Liao J., Pan X., Liang D., Zeng J., Sun M., Luo X., Ma X., Yin M., Ni J. How to make more people adopt healthy behaviors? Assessing health literacy, health promoting lifestyle and their association of community residents in Shenzhen, China. Front. Public Health. 2022;10:900883. doi: 10.3389/fpubh.2022.900883. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Zhou Y., Tang J., Zhang J., Wu Q. Impact of the coronavirus disease 2019 epidemic and a free influenza vaccine strategy on the willingness of residents to receive influenza vaccines in Shanghai, China. Hum. Vaccin. Immunother. 2021;17:2289–2292. doi: 10.1080/21645515.2020.1871571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.You Y., Li X., Jiang S., Liang J., Xie P., Zou X., Liu G., Han X. Can primary care physician recommendation improve influenza vaccine uptake among older adults? A community health centre-based experimental study in China. BMC Prim. Care. 2023;24:16. doi: 10.1186/s12875-023-01980-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Nagata J.M., Hernández-Ramos I., Kurup A.S., Albrecht D., Vivas-Torrealba C., Franco-Paredes C. Social determinants of health and seasonal influenza vaccination in adults ≥65 years: A systematic review of qualitative and quantitative data. BMC Public Health. 2013;13:388. doi: 10.1186/1471-2458-13-388. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Kwong E.W., Lam I.O., Chan T.M. What factors affect influenza vaccine uptake among community-dwelling older Chinese people in Hong Kong general outpatient clinics? J. Clin. Nurs. 2009;18:960–971. doi: 10.1111/j.1365-2702.2008.02548.x. [DOI] [PubMed] [Google Scholar]
  • 29.Wang J., Jing R., Lai X., Zhang H., Lyu Y., Knoll M.D., Fang H. Acceptance of COVID-19 Vaccination during the COVID-19 Pandemic in China. Vaccines. 2020;8:482. doi: 10.3390/vaccines8030482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.China National Influenza Center Summary of Influenza Epidemic in China (8th Weekly Report) [(accessed on 6 March 2023)]. Available online: https://ivdc.chinacdc.cn/cnic/zyzx/lgzb/202303/t20230302_264010.htm.
  • 31.McAnerney J.M., Walaza S., Cohen A.L., Tempia S., Buys A., Venter M., Blumberg L., Duque J., Cohen C. Effectiveness and knowledge, attitudes and practices of seasonal influenza vaccine in primary healthcare settings in South Africa, 2010–2013. Influenza Other Respir. Viruses. 2015;9:143–150. doi: 10.1111/irv.12305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Lytle K.L., Collins S.P., Feldstein L.R., Baughman A.H., Brown S.M., Casey J.D., Erickson H.L., Exline M.C., Files D.C., Gibbs K.W., et al. Influenza vaccine acceptance and hesitancy among adults hospitalized with severe acute respiratory illnesses, United States 2019–2020. Vaccine. 2021;39:5271–5276. doi: 10.1016/j.vaccine.2021.07.057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.National Bureau of Statistics of China Statistical Bulletin of the People’s Republic of China on National Economic and Social Development in 2021. [(accessed on 19 January 2023)]; Available online: http://www.stats.gov.cn/tjsj/zxfb/202202/t20220227_1827960.html.
  • 34.Shenzhen Bureau of Statistics Interpretation of the Main Data of the Seventh National Population Census of Shenzhen. [(accessed on 6 March 2023)]; Available online: http://tjj.sz.gov.cn/ztzl/zt/szsdqcqgrkpc/szrp/content/post_9138049.html.

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Data will be made available on request.


Articles from Vaccines are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES